Cases & Deals

  • Home
  • Practices
  • Nanobiotix completes €14.2 million (US$18.4 million) IPO

Share

Nanobiotix completes €14.2 million (US$18.4 million) IPO

October 2012

Client(s) Nanobiotix

Jones Day advised Nanobiotix, along with underwriters CM-CIC Securities, Gilbert Dupont, and BIL Finance, in connection with the €14.2 million (US$18.4 million) initial public offering and listing on the regulated market of NYSE Euronext in Paris, of Nanobiotix, a pioneer and leader in nanomedicine that has developed a revolutionary concept dedicated to the local treatment of cancer.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.